Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to understand whether there is any difference in the
amount of tasimelteon in the blood in smokers versus non-smokers. Additionally, this study
will provide an assessment of the effect, if any, of age and body size on the safety and
tolerability profile and the pharmacokinetics of tasimelteon.